Christine A Hrycyna

Title: Christine A Hrycyna: Innovator in Bioanalytical Devices and ABC Transporters

Introduction

Christine A Hrycyna is a notable inventor based in Lafayette, IN (US). She has made significant contributions to the field of bioanalytical devices and the inhibition of ATP-binding cassette (ABC) transporters. With a total of 2 patents, her work has implications for both medical and technological advancements.

Latest Patents

One of her latest patents focuses on the inhibition of ABC transporters by transmembrane domain analogs. This invention provides synthetic peptides derived from the transmembrane helices of ABC transporters, which inhibit their function by disrupting their structure. The peptides are designed with negatively charged residues to ensure correct orientation in the membrane, enhancing their solubility. Notable ABC transporters that can be inhibited by these peptides include MDR1, MRP1, MRP2, and BCRP. Additionally, the invention includes nucleic acids encoding the peptides, expression cassettes, and host cells expressing these cassettes. Another significant patent involves a bioanalytical device that utilizes asymmetric biofunctionalized membranes. This device features arrays of durable membranes containing protein transducers capable of unidirectional transport of analytes, including members of the ATP-binding cassette family.

Career Highlights

Christine has worked with reputable organizations such as the Purdue Research Foundation and the United States Department of Health and Human Services. Her innovative work has positioned her as a key figure in her field, contributing to advancements in both research and practical applications.

Collaborations

Throughout her career, Christine has collaborated with esteemed colleagues, including David H Thompson and Gil U Lee. These partnerships have further enriched her research and development efforts.

Conclusion

Christine A Hrycyna's contributions to the field of bioanalytical devices and ABC transporters highlight her innovative spirit and dedication to advancing technology. Her patents reflect a commitment to improving medical applications and enhancing our understanding of complex biological systems.